TSX open
Loading markets…

Advertisement

Stocks

Why Microbix Biosystems Inc. stock is rising today

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:MBX.TO

Get MBX alerts:

Photos provided by Pexels

Microbix Biosystems Inc. is seeing a noticeable increase in its stock price, reflecting positive market sentiment.

Microbix Biosystems Inc. (MBX.TO) shares are up 3.33% today, reaching CA$0.31. This rise comes as the company continues to grow in the biotechnology sector.

Advertisement

Microbix Biosystems Inc.

MBX.TO

Full stock page →

MBX.TO

Microbix Biosystems Inc.

Source:WealthAwesomeWealthAwesome
$0.06 (25.00%)
120 day period
$0.23$0.27$0.32Feb 24May 21Aug 14

Advertisement

Market cap

$41.25M

52W high

$0.32

52W low

$0.21

1W change

+3.45%

Beta

0.57

Analyst Price Targets

Based on analyst covering MBX

📈

Wall Street analysts forecast MBX stock price to rise 33.3% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.40

+33.3% Upside

Current Price

C$0.30

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Advertisement

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MBX's historical volatility

HistoricalForecast68%95%
C$0.21C$0.29C$0.37C$0.45C$0.54C$0.62TodayApr 8Jun 11Aug 14Sep 26Nov 9Dec 22

30-Day Vol

43.1%

Annualized

90-Day Vol

47.4%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$0.36

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.32C$0.27C$0.37
60 trading daysC$0.34C$0.27C$0.42
90 trading daysC$0.36C$0.28C$0.46

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Investor takeaway: Investors might find potential in Microbix's recent performance and upcoming financial disclosures, as the company works to strengthen its market position.

Microbix Biosystems Inc. Market Cap Reaches CA$41.25 Million

With a market cap of CA$41.25 million, Microbix operates in a niche area of the biotechnology industry, presenting both risks and opportunities for investors.

Bull case

The recent increase in stock price suggests that investors are gaining confidence in Microbix's strategic plans and its ability to grow its market share.

Bear case

Even with today's gains, the company faces challenges, such as a negative profit margin and the need for consistent revenue growth to attract long-term investors.

Recent Performance Overview

Advertisement

Microbix Biosystems Inc. has experienced a significant positive shift in its stock price today, with a 3.33% increase. This uptick is part of the company’s strategic efforts to expand its product offerings and market presence.

Market Sentiment and Future Prospects

The rise in Microbix's stock price may indicate growing investor confidence in the company’s future. With financial results expected soon, stakeholders are closely watching how the company will report its progress and growth strategies. Investors can learn more about Microbix's performance on our stock page.

Understanding the Risks

While the stock is rising today, investors should keep in mind the inherent risks, including the company’s current negative profit margin. As Microbix aims to strengthen its market position, potential investors should carefully weigh these factors against today’s positive performance.

Advertisement

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 17, 2026
Last Updated: August 17, 2026

Sponsored links

Advertisement